Scarica l'app Stockscreener
1.14
0.44%
0.01
Fibrobiologics Inc Borsa (FBLG) Ultime notizie
FibroBiologics receives European patent for fibroblast therapy - Investing.com
FibroBiologics, Inc. (FBLG) Stock Price, News, Quote & History - Yahoo! Finance Canada
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity - Morningstar
Nova Minerals and FibroBiologics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - Eagle-Tribune
FibroBiologics (FBLG) Slips 4.90% to $1.36 as Shares Drift Toward Key SupportVanna Flow - dars.gov.et
FibroBiologics Shareholders Approve Potential Warrant-Driven Share Issuance - TipRanks
FibroBiologics (NASDAQ: FBLG) raises $0.5M in insider deal - Stock Titan
Hamid Khoja Discloses Investment at FibroBiologics with 7.5% Stake - TradingView
Private deal gives FibroBiologics (FBLG) CSO hundreds of thousands of shares - Stock Titan
FBLG: Shareholders approved new share issuances as clinical and strategic progress was highlighted - tradingview.com
FibroBiologics CSO invests $500,000 in private placement By Investing.com - Investing.com
FibroBiologics, Inc. (NASDAQ:FBLG) CSO Invests ~$0.5M in Private Placement With Warrants - TradingView
Fibrobiologics Announces Closing of $0.5 Mill - Moomoo
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer - PR Newswire
FibroBiologics (FBLG) turns to a private stock-and-warrant deal for new funding - Stock Titan
Form 8K Fibrobiologics Inc For: 15 September By Investing.com - Investing.com Nigeria
FibroBiologics Announces Insider Private Placement Financing - TipRanks
FibroBiologics (FBLG) CSO to buy new shares and warrants in private deal - Stock Titan
Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications - ACCESS Newswire
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing - Yahoo Finance
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media - Morningstar
A new patent covers a way to promote repair in damaged spinal discs from FibroBiologics. - Stock Titan
About 80% of Americans experience lower back pain. FibroBiologics gets a European patent. - Stock Titan
FibroBiologics ships new batch of diabetic ulce... - Pluang
FibroBiologics ships third batch of trial drug to Australia - Investing.com
FibroBiologics ships third batch of trial drug to Australia By Investing.com - Investing.com India
FibroBiologics ships a third batch of wound treatment being tested to Australia - Stock Titan
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial - PR Newswire
FibroBiologics regains Nasdaq bid price compliance - Investing.com
FibroBiologics Regains Compliance with Nasdaq Trading Rules - PR Newswire
FibroBiologics Adds Sports Agent Leigh Steinberg to Board of Directors - citybiz
FibroBiologics appoints Leigh Steinberg to board By Investing.com - Investing.com Canada
Leigh Steinberg, agent behind $4B in deals, joins FibroBiologics (FBLG) board - Stock Titan
FibroBiologics | 10-Q: Q1 2026 Earnings Report - Moomoo
FibroBiologics receives Australian patent for disc disease therapy By Investing.com - Investing.com Canada
FibroBiologics receives Australian patent for disc disease therapy - Investing.com
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease - Morningstar
FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint Treatment - Sahm
FibroBiologics reports cartilage repair in animal study By Investing.com - Investing.com South Africa
FibroBiologics reports cartilage repair in animal study - Investing.com
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints - PR Newswire
Armistice Capital discloses 9.99% FibroBiologics (FBLG) stake via Master Fund - Stock Titan
FibroBiologics Inc - Smartkarma
FBLG Q2 2026 Earnings: Narrower Loss Beats Estimates as Pre-Revenue Biotech Advances Fibroblast Pipeline - vinanet.vn
FBLG Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 7.77% Share GainFinal Results - dars.gov.et
FibroBiologics receives patent for islet transplant method By Investing.com - Investing.com UK
FibroBiologics receives patent for islet transplant method - Investing.com
Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts - TradingView
FibroBiologics Patent Could Help Stretch Scarce Donor Pancreases - Stock Titan
FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets - PR Newswire
FBLG Q2 2026 Earnings: Narrower Loss Beats Estimates as Pipeline AdvancesEPS Guidance Update - dars.gov.et
1.14%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):